From: Left ventricular non-compaction cardiomyopathy and left ventricular assist device: a word of caution
 | No. | Patients | Device | Duration of support | Complications | Outcome |
---|---|---|---|---|---|---|
Maile et al., 2004 [4] | 1 | Male, 51Â years | DeBakey MicroMed LVAD | 2.5Â months | None | Successfully bridged to transplantation |
Ivan et al., 2005 [6] | 2 | Male, 21Â years | Jarvik biventricular assist device | Not indicated | Not indicated | Death before transplantation |
 |  | Male, 37 years | Thoratec RVAD and HeartMate LVAD | Not indicated | Not indicated | Death after transplantation |
Nathan et al., 2010 [9] | 1 | Male, 14Â years | Abiomed, biventricular assist device | 5Â days | None | Successfully bridged to transplantation |
Ninios et al., 2010 [5] | 1 | Male, 28Â years | Jarvik 2000 LV | 3Â years | Recurrent thrombosis with successful intravenous lysis | Patient on LVAD support at the date of publication |
Hanke et al., 2012 [10] | 1 | Male, 12Â months | Berlin Heart, Excor, biventricular assist device | 24Â days | Pulmonary haemorrhage requiring use of a membrane oxygenator, thrombosis requiring replacement of the LVAD | Successfully bridged to transplantation |
Siehr et al., 2013 [11] | 1 | Male, 6Â weeks | Berlin Heart, Excor, LVAD | 56Â days | Embolic cerebrovascular accident, 2 pump exchanges due to clot formation | Successfully bridged to transplantation |
Uribarri et al., 2015 [7] | 5 | 4 males (23, 25, 43,54 years) 1 female (24 years) | 3 HVAD 2 HeartMate II | Mean follow up period 86.5 weeks, range 40–194 weeks | 4 cases of pump thrombosis in 3 of 5 patients | 2 deaths, 3 patients on LVAD support at the date of publication |